> Medical device maker Koning said its Koning Breast Computed Tomography system has received approval from the China Food and Drug Administration. Release
> Switzerland's Clariant said it will invest about $10 million to set up a healthcare packaging plant in the Indian state of Tamil Nadu. Report
> India's Aurobindo said it has received approval from the U.S. Food and Drug Administration to sell its generic version of the osteoporosis drug risedronate sodium. Report
> India's Jubilant Life Sciences said it has received approval from the U.S. Food and Drug Administration to sell its generic version of the anti-depressant Paxil. Report
> Tigermed Pharmaceutical Technology said it has acquired 98.14% of South Korea's DreamCIS for $28 million. Report
> China's HUYA Bioscience International said it has opened a corporate office in South Korea to help local companies with clinical trials and drug approvals. Release
> Britain's MR Solutions said it has signed a deal to supply MRI imaging systems to the Japanese market in partnership with Japan's Summit Pharmaceuticals. Report
> A newly developed drug to treat advanced melanoma has been given "low priority" for government funding in New Zealand because of questions over the "magnitude and durability of the benefits" for patients. Report
> The U.S. subsidiary of Japan's Shionogi said it has started a Phase III trial to evaluate the safety and efficacy of its Osphena treatment for vaginal dryness. Release
> A national web portal available to Indians to register complaints about the country's pharmaceutical industries showed the availability of medicines remained a challenge. Report
> Japan's Kyowa Hakko Kirin is partnering with Kyoto University's Center for iPS Cell Research and Application to research the use of stem cells in cancer immunotherapy. Report
> Sweden's Affibody said work on its Albumod platform and the initiation of a Phase I clinical trial has triggered a milestone payment from partner Daiichi Sankyo. The amount was not disclosed. Release
> Indian generic giant Sun Pharma has teamed up world champion snowboarder Kelly Clark as part of its patient education program for the acne drug Absorica. Release